看起來你不是TradeKey.com的會員。 立即註冊,與全球超過7百萬的進口商和出口商建立聯繫。 点击注册--免费! |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
Next

(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

离岸价格

获取最新报价

( Negotiable )

|

100 Gram Minimum Order

国家:

China

型号:

IP0004-F

离岸价格:

( Negotiable ) 获取最新报价

位置:

china

最小订单价格:

-

最小订单:

100 Gram

包装细节:

Aluminum foil bag, PTFE Bottle, or meet your requirment

交货时间:

Within one week

供应能力:

1 Kilogram per Month

付款方式:

D/P, L/C, T/T

现在联系
免费会员

联系人 Mr. James

Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai

现在联系

产品规格

  • Other Names: (E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
  • Type: Pharmaceutical Intermediates
  • Purity (%): 99%
  • Brand Name: YD
  • Application: pharm intermediate
  • Appearance: white powder

详情

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer.

国家: China
型号: IP0004-F
离岸价格: ( Negotiable ) 获取最新报价
位置: china
最小订单价格: -
最小订单: 100 Gram
包装细节: Aluminum foil bag, PTFE Bottle, or meet your requirment
交货时间: Within one week
供应能力: 1 Kilogram per Month
付款方式: D/P, L/C, T/T
產品組 : Pharma intermediate

Send a direct inquiry to this supplier

至:

Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >

我想知道: